In this preclinical study, we assessed feasibility of evaluating Gadolinium deposition in cortical bone by using recently developed actual flip angle variable repetition time 3D ultrashort echotime technique in rabbit model at 7T. Twenty times of administration of clinical equivalent dose of Magnevist and Gadovist that normalized according to body surface by U.S. FDA recommendation, and three times the dose of Gadovist (high-dose group) were investigated. Significant lower T1 values were observed in Magnevist administration group, Gadovist administration group and high-dose Gadovist administration group compared to control group, suggested T1 mapping might be a potential biomarker for evaluating Gadolinium deposition.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords